Ala S. Dababneh

GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia

Zelalem Temesgen, Mariam Assi, Fnu Shweta et al. · Mayo Clinic Proceedings · 2020 · 88 citations · Full text

Life Sciences, Immunology, Infectious Diseases +7

A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19

Raymund R. Razonable, Nicole C.E. Aloia, Ryan J. Anderson et al. · Mayo Clinic Proceedings · 2021 · 54 citations · Full text

Pharmacy, Health Informatics, Infectious Diseases +17

Reevaluation of Commercial Reagents for Detection of Histoplasma capsulatum Antigen in Urine

Elitza S. Theel, Julie Harring, Ala S. Dababneh et al. · Journal of Clinical Microbiology · 2015 · 53 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathology +16

Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research

John C. O’Horo, James R. Cerhan, Elliot J. Cahn et al. · Mayo Clinic Proceedings · 2020 · 31 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12

First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe and Critical COVID-19 Pneumonia

Zelalem Temesgen, Mariam Assi, Paschalis Vergidis et al. · medRxiv · 2020 · 27 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10